Oxular’s technologies were developed together to find solutions that would solve significant remaining unmet challenges in retinal care. Together, these systems will transform the treatment of retinal disorders.
Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better kinetics and therapeutic benefits. They can provide treatment effects lasting up to 12 months from a single administration.
Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal spaces.
Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better kinetics and therapeutic benefits. They can provide treatment effects lasting up to 12 months from a single administration.
Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal spaces.
If you would like to discuss a potential partnership with Oxular, please contact us via the form linked below.
General
+44 (0)1865 636200
inquiries@oxular.com
Magdalen Centre
1 Robert Robinson Avenue
Oxford, OX4 4GA, UK
Limited company registered in
England and Wales
Registration No. 09331313
VAT No. GB 244 5883 81
Copyright Oxular Limited
Media
+1 617 895 9511
monique@thrustsc.com
Monique Allaire
Thrust
Follow us on
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting